0
ARTICLE |

Oral Contraceptives and Cervical Cancer-Reply

Kathleen L. Irwin, MD; Mark W. Oberle, MD, MPH; Nancy C. Lee, MD; Luis Rosero-Bixby
JAMA. 1988;259(18):2696-2697. doi:10.1001/jama.1988.03720180024022.
Text Size: A A A
Published online

In Reply.  —Dr Celentano correctly points out that the negative associations found in our case-control study of oral contraceptives and invasive cervical cancer in Costa Rica and in his study in inner-city Baltimore1 may reflect detection bias, rather than a truly protective effect. If oral contraceptive users are more likely to receive cervical smears than nonusers, they are more likely to be identified as having the disease before the invasive stage of cervical cancer and then to receive treatment. Thus, oral contraceptive users may be under-represented among cases of invasive cervical cancer, resulting in a spurious negative association.A lifetime history of one or more cervical smears is more common in the United States than in Costa Rica.2 Despite the overall higher screening prevalence in the United States, Celentano et al reported that the enhanced screening of oral contraceptive users we found in Costa Rica also occurs in

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs